Ronald M. Klabe

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Journal of Medicinal Chemistry · 2000 · 301 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas

Patrick Y. S. Lam, Yu Ru, Prabhakar K. Jadhav et al. · Journal of Medicinal Chemistry · 1996 · 170 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models

Phillip C.C. Liu, Holly K. Koblish, Liangxing Wu et al. · PLoS ONE · 2020 · 161 citations · Full text

Medicine, Oncology, Pharmacology +14

Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Antimicrobial Agents and Chemotherapy · 1999 · 119 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Preparation and Structure−Activity Relationship of Novel P1/P1‘-Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors

David A. Nugiel, Kim Jacobs, Tabitha V. Worley et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +11